SA COLD AND FLU REMEDY INDUSTRY LANDSCAPE REPORT - Insight Survey

SA COLD AND FLU REMEDY INDUSTRY LANDSCAPE REPORT

COMPILED: FEBRUARY 2017

REPORT OVERVIEW

The South African Cold and Flu Remedy Industry Landscape Report (105 pages) provides a dynamic synthesis of industry research, examining the local and global Cold and Flu Remedy industry from a uniquely holistic perspective, with detailed insights into the entire value chain ? from manufacturing to retail, pricing analysis and consumption trends. .

SOME KEY QUESTIONS THE REPORT WILL HELP YOU TO ANSWER:

For the Global Cold and Flu Remedy Industry Section: What are the current market dynamics of the Global Cold and Flu Remedy industry? What are the Global Cold and Flu Remedy industry trends, drivers, and restraints?

For the South African Cold and Flu Remedy Industry Section: What are the current market dynamics of the SA Cold and Flu Remedy industry? Who are the key manufacturing players in the SA Cold and Flu Remedy industry? What are the South African industry trends, drivers and challenges?

For the South African Retail and Pricing Analysis Section: Who are the key retail players (retail outlets and independent pharmacies) in the SA Cold and Flu Remedy industry? What are the prices of Cold and Flu Remedy across SA retail outlets?

In terms of South African Consumer Insights and Trends: How many people in South Africa are using Cold and Flu Remedies (2011-2015)? What are the statistics regarding volume usage among Cold and Flu Remedies (2011-2015)?

2

SCREENSHOTS FROM REPORT

105 page report filled with detailed charts, graphs, tables and insights

3

SAMPLE FROM REPORT:

GLOBAL KEY MARKETS OVERVIEW

Globally the largest OTC markets were China and the USA which accounted for 44.6% of the global OTC market in 2016 (as illustrated in the graph).

These countries were responsible for a slightly higher proportion of global OTC growth of 46.6% in the first quarter of 2016.

Slower growth was observed in Europe and North America due to the decrease in cold and flu remedies growth while Japan showed renewed life.

TOP 10 BEST PERFORMING OTC MARKETS BY NET CONTRIBUTION IN Q1 2016 (IN MILLION US$)

1,600 1,400 1356

1,200 1,000

1029

800

600

400 200

262 233 175 114 62 58 51

1

0

Million US Dollars

Europe and North America are the most important markets within the global Cold and Flu Remedy industry.

Based on geography, the global Cold and Flu Remedy market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific (excluding Japan), and the Middle East and Africa.

North America is the largest revenue generating segment in the global Cold and Flu Remedy market, followed by Europe.

The increasing prevalence of viral infections and rapid economic developments benefiting healthcare sectors in Asian countries are projected to drive the growth of the Cold and Flu Remedy market in Asia.

4

Source: Futuremarketinsights; Nicholashallcompany

Image Source: Freepik

SAMPLE FROM REPORT:

SOUTH AFRICAN INDUSTRY TRENDS

South African consumers have become more health conscious.

The demand for health and wellness products, including herbal medicines, have seen strong growth as South African consumers become increasingly health conscious.

Many companies are thus focusing on providing products made from natural herbs rather than chemicals.

Better quality products.

Instead of manufacturers only improving the strength of their products, they are improving the taste ? especially for children's products as well as making products more specialized for specific ailments, but that also covers more than one symptom.

Manufacturers are also trying to differentiate their products by providing products better suited to daytime and a different one suited to night time.

Increase of generic medication in South Africa.

The popularity of generic medication has been on the rise in South Africa for several years. The opinion of generic medications is changing in South Africa, even if many doctors and patients perceive generics to be inferior to brand name medication.

According to Vivian Fritelli, CEO of the National Association of Pharmaceutical Manufacturers, it is important to change this perception of generic products to help consumers realize the important savings they can get from generics. The IMS Health estimates that every 1% increase in generic utilization translates into a saving of R270 million for the consumer.

Source: How we made it in Africa, Health24

Image source: Integrative; Freepik

5

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download